Matches in Wikidata for { <http://www.wikidata.org/entity/Q92847584> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92847584 description "2019 թվականի օգոստոսի 10-ին հրատարակված գիտական հոդված" @default.
- Q92847584 description "article scientifique publié en 2019" @default.
- Q92847584 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92847584 description "scientific article published on 10 August 2019" @default.
- Q92847584 description "wetenschappelijk artikel" @default.
- Q92847584 description "наукова стаття, опублікована 10 серпня 2019" @default.
- Q92847584 name "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 name "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 type Item @default.
- Q92847584 label "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 label "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 prefLabel "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 prefLabel "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 P1433 Q92847584-23296A14-C114-4242-A326-232F821E47A7 @default.
- Q92847584 P1476 Q92847584-1CEA4C38-F52E-4C58-B556-75666CF485F4 @default.
- Q92847584 P2093 Q92847584-14EA0CD6-9847-42C0-85D4-51AFF143FF94 @default.
- Q92847584 P2093 Q92847584-81625BEB-3423-467D-AABC-DBB18CF31D50 @default.
- Q92847584 P2093 Q92847584-825CB49A-840E-4A9D-A7F1-682AB99832B9 @default.
- Q92847584 P2093 Q92847584-BD99CA4A-7309-4536-B95F-EB11D3E2A2B7 @default.
- Q92847584 P2093 Q92847584-BF40D1E9-5F86-45ED-934C-5CB75D3CEE8B @default.
- Q92847584 P2093 Q92847584-C054A7C4-B8CF-4C51-B79E-1F1B77D1FAA0 @default.
- Q92847584 P2093 Q92847584-D19ABA48-2745-493D-8713-BDC02BA6C502 @default.
- Q92847584 P304 Q92847584-D0A474E3-A31D-47BE-A678-7246DEF3318F @default.
- Q92847584 P31 Q92847584-A7F50D39-65FB-4F11-9509-AD813ED34D4D @default.
- Q92847584 P356 Q92847584-A08FF2E4-9536-45D9-9742-F09D3B2094F3 @default.
- Q92847584 P478 Q92847584-E621A7BE-EA79-438E-8401-CD426EA8B9C0 @default.
- Q92847584 P577 Q92847584-C13415CB-D832-48C2-97B8-D6D382391759 @default.
- Q92847584 P698 Q92847584-E5DD2F88-EE77-47EA-867E-E81A3B93BF8E @default.
- Q92847584 P921 Q92847584-98E783D5-71C0-49FE-84CE-4AA082D87088 @default.
- Q92847584 P356 J.JPBA.2019.112802 @default.
- Q92847584 P698 31446298 @default.
- Q92847584 P1433 Q15752537 @default.
- Q92847584 P1476 "Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate" @default.
- Q92847584 P2093 "Amelia Cudd" @default.
- Q92847584 P2093 "Caroline Palais" @default.
- Q92847584 P2093 "Emilie Poirier" @default.
- Q92847584 P2093 "Jason Dowd" @default.
- Q92847584 P2093 "Shanthi Rajendran" @default.
- Q92847584 P2093 "Stephen Brokx" @default.
- Q92847584 P2093 "Tudor Arvinte" @default.
- Q92847584 P304 "112802" @default.
- Q92847584 P31 Q13442814 @default.
- Q92847584 P356 "10.1016/J.JPBA.2019.112802" @default.
- Q92847584 P478 "176" @default.
- Q92847584 P577 "2019-08-10T00:00:00Z" @default.
- Q92847584 P698 "31446298" @default.
- Q92847584 P921 Q413299 @default.